MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)
source: myfinsight.com
Download
Download image
Net change in cash
and cash...
-$1,084,515
Non-cash lease expense
$159
Net cash flows from
operating activities
-$1,084,515
Canceled cashflow
$159
Net loss
-$686,425
Accounts payable and
other current...
-$384,781
Prepaid expenses
$13,835
Back